Welcome to our dedicated page for Atlas Energy news (Ticker: CANSF), a resource for investors and traders seeking the latest updates and insights on Atlas Energy stock.
This page contains historical and current news coverage for the stock trading under the symbol CANSF. This ticker originally represented Willow Biosciences Inc, a Canadian biotechnology company that developed precision fermented ingredients. The company has since undergone a corporate transformation and now operates as Atlas Energy Corp., an international upstream oil and gas royalty and streaming company.
The news archive documents Willow Biosciences' history in the precision fermentation industry, including its FutureGrown and BioOxi technology platforms, strategic review process, and the eventual sale of its operating subsidiary. More recent coverage reflects Atlas Energy Corp.'s activities in the oil and gas royalty sector, including recapitalization announcements, listing updates, and financial results from the transformed entity.
Investors researching CANSF should review both the historical biotechnology coverage and current energy sector news to understand the complete trajectory of this investment. The transformation from a development-stage biotech company to an oil and gas royalty business represents a fundamental change in risk profile, industry dynamics, and investment thesis. News from the Willow Biosciences era provides context on the company's origins, while Atlas Energy Corp. coverage reflects the current business strategy and financial performance.
Willow Biosciences Inc. (OTCQB: CANSF) has announced a commercial agreement with Sandhill One, LLC, following successful development of their BioOxi™ bio-oxidation platform for ursodeoxycholic acid (UDCA). This bioactive compound is essential in treating cholestatic liver disease and gallstone conditions. The innovative collaboration aims to provide a more sustainable, cost-effective production method for UDCA, eliminating reliance on animal-sourced materials. Willow anticipates receiving a significant percentage of Sandhill’s end-market revenues, enhancing potential royalty income. The agreement underscores Willow's commitment to expanding company growth and achieving targeted milestones for 2023.